Breaking News
Diesel Is the Pretext...
Your Opportunity to Weigh In on Federal Vaccine Policy - Deadline Sunday Sept 20
Palantir $PLTR CEO Alex Karp says "AI companies have to be nationalized"
It's infuriating that they know better, but sell us out until they leave
Top Tech News
World's smallest CT scanner fits in the palm of your hand
The Tesla Roadster will blow people's minds
Peter Thiel-Funded Company Anduril to Triple the Number of Autonomous Surveillance Towers...
Quantum computing may soon become part of the microscope itself.
Volkswagen Just Unveiled The Most Efficient EV Ever Tested
NASA Super Light Solar Sail Project Will Be 12-40 Times Lighter and Faster
Space Telescope Interferometer to Image Exoplanet Continents
Twenty-five years of "temporary": how 9/11 built a surveillance state Americans never vote
I'll Never Buy Another WALMART Battery!
Shoei GT-Air 3 Smart helmet drops with built-in AR for $1,500
Single gene therapy injection surprisingly boosts vision in both eyes
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.